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NK cells are key components of the innate 
immune response to infectious pathogens (1, 2). 
Activated NK cells are an early source of IFN-γ 
and thereby contribute to the development of 
type 1 Th cells (3, 4). They support the matura-
tion of DCs (5, 6) and can exhibit cytolytic 
  activity against host cells infected with certain 
viruses, bacteria, or protozoa (7–9). The acti-
vation of NK cells is a multifactorial process 
that involves soluble factors as well as stimu-
latory cell surface receptors that are triggered 
  during interaction with ligand-positive target 
cells (10). In vitro studies revealed that human 
or mouse DCs can activate resting NK cells via 
direct cell–cell contact or the release of cytokines 
(e.g., IFN-α/β, IL-2, IL-12, and IL-18; 
reference 6). Depletion of a subset of lymphoid 
DCs (CD8α+) by anti-CD8 antibody treatment, 
which is not selective for DCs, partially abro-
gated fms-like tyrosine kinase 3 ligand (Flt3L)-
induced and NK cell–mediated tumor regression 
and impaired the expansion of Ly49H+ NK 
cells during murine cytomegalovirus infection 
(11, 12), but in vivo evidence for DC-dependent 
regulation of NK cell IFN-γ expression and 
  cytotoxicity has not yet been published.
More recent in vitro studies on human DC 
populations and NK cells suggested that in ad-
dition to conventional or myeloid DCs (mDCs; 
CD11chigh) plasmacytoid DCs (pDCs) can also 
activate NK cells for cytolytic activity in a type 
I IFN-α/β–dependent manner (13, 14). Mouse 
pDCs express a unique selection of myeloid 
and lymphoid cell surface markers (CD11b−, 
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Natural killer (NK) cells are sentinel components of the innate response to pathogens, but 
the cell types, pathogen recognition receptors, and cytokines required for their activation 
in vivo are poorly defi  ned. Here, we investigated the role of plasmacytoid dendritic cells 
(pDCs), myeloid DCs (mDCs), Toll-like receptors (TLRs), and of NK cell stimulatory cytokines 
for the induction of an NK cell response to the protozoan parasite Leishmania infantum. 
In vitro, pDCs did not endocytose Leishmania promastigotes but nevertheless released 
interferon (IFN)-𝗂/𝗃 and interleukin (IL)-12 in a TLR9-dependent manner. mDCs rapidly 
internalized Leishmania and, in the presence of TLR9, produced IL-12, but not IFN-𝗂/𝗃. 
Depletion of pDCs did not impair the activation of NK cells in L. infantum–infected mice. 
In contrast, L. infantum–induced NK cell cytotoxicity and IFN-𝗄 production were abolished 
in mDC-depleted mice. The same phenotype was observed in TLR9−/− mice, which lacked 
IL-12 expression by mDCs, and in IL-12−/− mice, whereas IFN-𝗂/𝗃 receptor−/− mice showed 
only a minor reduction of NK cell IFN-𝗄 expression. This study provides the fi  rst direct 
evidence that mDCs are essential for eliciting NK cell cytotoxicity and IFN-𝗄 release in vivo 
and demonstrates that TLR9, mDCs, and IL-12 are functionally linked to the activation of 
NK cells in visceral leishmaniasis.
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CD11cint, B220+, Ly6C+, Gr-1+, CD62L+, and CD45RA+; 
reference 15). They release large amounts of IFN-α/β in vitro 
and in vivo in response to DNA or RNA viruses, bacterial 
DNA, or synthetic oligodeoxynucleotides (ODNs) with un-
methylated CpG motifs (CpG ODN; reference 15), synthetic 
guanosine-uridine (GU)-rich single-stranded RNA (ssRNA; 
references 16 and 17), or purifi  ed or synthetic hemozoin (18). 
In each of these cases, the production of IFN-α/β was de-
pendent on Toll-like receptor (TLR)7 or TLR9, which are 
typically expressed by mouse pDCs (19). Both TLRs signal 
through the adaptor molecule myeloid diff  erentiation factor 
88 (MyD88), which recruits further signaling molecules and 
fi  nally leads to the activation of NF-κB or IFN regulatory 
factor (IRF)-7, followed by rapid IFN-α/β expression (20).
A protective immune response against intracellular proto-
zoan parasites of the genus Leishmania is characterized by the 
induction and expansion of IFN-γ–producing CD4+ and 
CD8+ T cells, which activate macrophages for the expression 
of antileishmanial eff  ector pathways such as inducible nitric 
oxide synthase (21, 22). In the mouse models of experimental 
cutaneous (e.g., Leishmania major) and visceral (e.g., Leishmania 
donovani and Leishmania infantum) leishmaniasis, NK cells were 
found to participate in the innate immune response and con-
trol of the parasites (23–31). Endogenous and exogenous 
IL-12 or IFN-α/β were shown to confer NK cell activation 
(25, 28–30, 32, 33) and/or protective immunity in these 
models (21, 25, 29, 34–37). Furthermore, in vitro stimulation 
assays with pro- or amastigote parasites and certain mouse 
DCs (38–40), ex vivo immunohistochemical or fl  ow cyto-
metry analyses of lymphatic tissues (41, 42), as well as DC trans-
fer and vaccination studies (43) identifi  ed DCs as a source of 
IL-12 during Leishmania infections. However, it is unknown 
how Leishmania parasites are initially sensed by the immune 
system to trigger an innate NK cell response during the early 
phase of Leishmania infection and whether the activation of 
NK cells in vivo requires interaction with CD11chigh mDCs, 
CD11cint pDCs, and/or mDC-/pDC-derived cytokines.
In this study, we investigated which DC population, 
pathogen recognition receptor, and cytokine is essential for 
the induction of NK cell cytotoxicity and IFN-γ production 
in visceral leishmaniasis. Our parallel analysis of pDCs and 
mDCs revealed that only pDCs, but not mDCs, produced 
IFN-α/β after stimulation with L. infantum promastigotes, 
whereas pDCs as well as mDCs released IL-12. The Leishmania-
induced production of both cytokines was strictly depen-
dent on TLR9. Unexpectedly, pDCs (and, to a large extent, 
IFN-α/β receptor [IFNAR] signaling) were dispensable for 
the innate NK cell response to L. infantum in vivo. Instead, 
the activation of splenic NK cells after L. infantum infection 
required CD11chigh mDCs, TLR9, and IL-12.
RESULTS
Differential production of IFN-𝗂/𝗃 and IL-12p40 by pDCs 
and mDCs in response to Leishmania promastigotes
Although mDCs are well-known targets of Leishmania, the 
  interaction of pDCs with Leishmania has not yet been studied. 
Therefore, we investigated whether pDCs are targets of 
  Leishmania parasites. Flt3L-expanded BM cells of C57BL/6 
mice were exposed to Leishmania promastigotes and ana-
lyzed for the expression of costimulatory surface mole-
cules. L. infantum and L. major promastigotes up-regulated 
the expression of CD40, CD80, and CD86 on mPDCA-
1+CD11b−CD11c+ BM-derived pDCs (BM-pDCs; as well 
as on CD11b+CD11c+ BM-derived mDCs [BM-mDCs]) 
within the Flt3L culture, although to a lesser extent than 
the known pDC activator CpG ODN 2216 (Fig. S1 A, 
which is available at http://www.jem.org/cgi/content/full/
jem.20061293/DC1, and not depicted; reference 19).
Figure 1.  IFN-𝗂/𝗃 expression in pDCs versus mDCs. Cells were stim-
ulated with 1 μM CpG ODN 2216, 50 ng/ml poly(I:C), 200 ng/ml LPS, 
L. infantum, L. major, or L. braziliensis promastigotes (MOI = 3) ± anti-
mCD40 mAb (5 μg/ml). (A) IFN-α/β production of sorted C57BL/6 
BM-pDCs (Flt3L-BM culture) or BM-mDCs (GM-CSF-BM culture) after 
stimulation for 48 h. Mean ± SEM of two experiments. (B) IFN-α and 
IFN-β mRNA expression of sorted C57BL/6 BM-pDCs after stimulation for 
24 h as determined by real-time RT-PCR. Mean (±SD) of the calculated 
relative expression of seven independent experiments. (C) IFN-α/β pro-
duction of purifi  ed splenic pDCs or splenic mDCs of 129Sv mice stimu-
lated in parallel. Mean ± SEM of two experiments. ▼, not detectable.JEM VOL. 204, April 16, 2007  895
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Next, we compared the cytokine expression of C57BL/6 
BM-pDCs (CD11b−CD11c+CD62L+ cells sorted from 
Flt3L-expanded BM cultures) and BM-mDCs (CD11b+-
CD11c+CD86low cells sorted from GM-CSF–  expanded 
BM cultures) after stimulation with live Leishmania promasti-
gotes (multiplicity of infection [MOI] = 3, unless stated 
otherwise). pDCs generated copious amounts of IFN-α/β 
as detected by bioassay (Fig. 1 A) or ELISA (Fig. S1 C). 
Among all Leishmania species tested (L. major, L. infantum, 
and Leishmania braziliensis), L. infantum induced the highest 
release of IFN-α/β protein in 48 of a total of 58 experi-
ments, which frequently was only one order of magnitude 
lower than the amount of IFN-α/β elicited by HSV-1 virus 
or CpG ODN 2216 (Fig. 1 A and Fig. S1 B). Real-time 
RT-PCR revealed a 10–1,000-fold induction of the mRNA 
expression of IFN-β and, with the exception of IFN-α11 
and IFN-α13, of all IFN-α subtypes tested (Fig. 1 B). mDCs, 
in contrast, produced strikingly less IFN-α/β in response to 
CpG ODN 2216 and virtually no IFN-α/β after exposure 
to Leishmania parasites (Fig. 1 A).
Leishmania promastigotes also activated purifi  ed splenic 
pDCs (CD11b−CD11cintGr-1+) for the production of IFN-
α/β, whereas no IFN-α/β was detectable in the culture 
  supernatants of purifi  ed splenic mDCs (CD11chighMHCII+; 
Fig. 1 C). Poly(I:C), which targets TLR3, and LPS, which 
interacts with TLR4, were inactive on BM-pDCs and splenic 
pDCs but elicited an IFN-α/β response in BM-mDCs and 
splenic mDCs (Fig. 1, A and C, and not depicted).
BM-pDCs co-cultured with Leishmania promastigotes 
  released TNF, but not MIP-2α or nitric oxide (not depicted). 
Both BM-pDCs and BM-mDCs produced IL-12p40 after 
stimulation with CpG ODN 2216 or Leishmania promasti-
gotes. The CpG- or Leishmania-induced IL-12p40 release of 
mDCs was higher compared with pDCs and enhanced by 
anti-CD40 (see WT pDCs and mDCs in Fig. 2 D). IL-12p70 
remained undetectable (not depicted).
These data demonstrate that Leishmania promastigotes 
potently activate mouse pDCs, but not mDCs, for the ex-
pression of IFN-α/β mRNA and protein, whereas both DC 
populations are triggered for the release of IL-12p40.
The induction of IFN-𝗂/𝗃 and/or IL-12 in pDCs and mDCs 
by Leishmania requires TLR9
The data presented above raised the question of which patho-
gen recognition receptor(s) on the surface of pDCs and 
mDCs transmits the signal for the induction of IFN-α/β 
and/or IL-12 by Leishmania.
Mouse pDCs express a very limited spectrum of TLRs 
(TLR7 and TLR9), which all signal via the MyD88 adaptor 
molecule (19). When sorted WT and MyD88−/− BM-pDCs 
were exposed to Leishmania promastigotes or CpG ODN 
2216, we found that both the CpG- and the Leishmania-
  induced IFN-α/β release were entirely dependent on MyD88 
(Fig. 2 A). The IFN-α/β production in response to L. infantum 
or L. major was completely abolished in the absence of TLR9 
in seven out of eight experiments (in one experiment, the 
IFN-α/β release was  100 U/ml). After stimulation of 
TLR9−/− BM-pDCs with L. braziliensis, IFN-α/β was un-
detectable in three of eight experiments and reduced by >95% 
in the remaining experiments (Fig. 2 B). As expected, CpG 
ODN 2216 did not induce any IFN-α/β in TLR9−/− pDCs 
(Fig. 2 B), whereas synthetic GU-rich ssRNA, a TLR7   ligand 
(16, 17), clearly triggered the release of IFN-α/β (mean U/ml ± 
SEM of two experiments: 8,789 ± 3,096).
The production of IFN-α/β during viral infections or in 
response to certain TLR9 ligands is regulated by a positive 
feedback loop in which the early secreted IFN-β and IFN-α4 
initiate further IFN-α/β expression via IFNAR-mediated de 
novo synthesis of IRF-7 (15, 20). As pDCs constitutively ex-
press high levels of IRF-7 and release huge amounts of IFN-α 
even in the absence of an autocrine feedback loop (15, 44), we 
tested whether the Leishmania-induced IFN-α/β production 
Figure 2.  Receptors involved in Leishmania-induced expression of 
IFN-𝗂/𝗃 and/or IL-12p40. Sorted BM-pDCs (from Flt3L-BM culture) 
and sorted immature BM-mDCs (from GM-CSF-BM culture) of C57BL/6 
WT, MyD88−/−, TLR9−/−, IFN-β−/−, or IFNAR−/− mice were analyzed. 
After stimulation with 1 μM CpG ODN 2216, L. infantum, L. major, or 
L. braziliensis promastigotes (MOI = 3) for 48 h, the (A–C) IFN-α/β 
  content (VSV bioassay) or the (D) IL-12p40 content (ELISA) of the 
  respective culture supernatants was determined. Mean ± SEM of three 
(A and C), eight (B), or two independent experiments (D). ▼, not detect-
able. Signifi  cant differences between WT and KO cells are indicated as 
follows: *, P < 0.05; **, P < 0.01; ***, P < 0.005.896  PDCS, MDCS, TLR9, AND LEISHMANIA | Schleicher et al.
requires endogenous IFN-α/β signaling. No IFN-α/β was 
detectable in the cultures of sorted C57BL/6 BM-pDCs defi  -
cient for the IFNAR chain 1 (IFNAR−/−) that were stimu-
lated with Leishmania parasites or CpG ODN 2216. The 
IFN-α/β production triggered by Leishmania was also mark-
edly reduced in IFN-β−/− pDCs (Fig. 2 C).
In both BM-pDCs and BM-mDCs, the IL-12p40 pro-
duction elicited by the TLR9 ligand CpG ODN 2216 or by 
viable Leishmania promastigotes was entirely dependent on 
the presence of TLR9 (Fig. 2 D).
Collectively, these data illustrate that TLR9 is essential for 
the Leishmania-mediated induction of two major NK cell–
  activating cytokines (IFN-α/β and IL-12) in pDCs and 
mDCs. In addition, the generation of IFN-α/β by pDCs co-
cultured with Leishmania promastigotes requires an IFNAR-
dependent feedback loop that is partially maintained by IFN-β.
Leishmania-induced IFN-𝗂/𝗃 production by pDCs does not 
require replication, stage maturation, viability, or uptake 
of the parasites and can be mimicked by Leishmania DNA
To characterize the parasite requirements for the induction 
of IFN-α/β, we exposed sorted C57BL/6 BM-pDCs to 
(a) viable promastigotes of the logarithmic or stationary growth 
phase; (b) viable, but irradiated (i.e., replication-defi  cient) 
promastigotes; (c) freeze-thaw lysates of stationary-phase 
Leishmania promastigotes; or to (d) boiled lysates of Leishmania 
promastigotes. In all these cases, the induction of IFN-α/β 
was in the same order of magnitude (Fig. 3 A, top, and not 
depicted), indicating that neither a specifi  c parasite stage nor 
a productive infection of the host cells is required and that 
proteins are unlikely to be the only active component of 
Leishmania promastigotes. However, when pDCs were cul-
tured with viable L. infantum promastigotes in the presence of 
DNase, we observed a signifi  cant (approximately fourfold) 
reduction of the IFN-α/β content in the culture superna-
tants (Fig. 3 A, top). This raised the possibility that Leishmania 
DNA at least partially accounts for the stimulatory activity of 
whole parasites.
Eukaryotic DNA contains unmethylated CpG-DNA 
motifs, which might cause TLR9-dependent stimulation of 
immune cells (45–47). When C57BL/6 BM-pDCs were 
stimulated with 0.5–5 μg/ml genomic DNA (gDNA) from 
L. infantum promastigotes, the production of IFN-α/β was 
similar to that after co-culture with viable L. infantum para-
sites at an MOI of 3 (Fig. 3 A, bottom). At low concentra-
tions (0.1 μg/ml), L. infantum gDNA induced only small 
(<300 U/ml; six experiments) or undetectable quantities of 
IFN-α/β (eight experiments; Fig. 3 A, bottom), whereas the 
equivalent number of whole parasites (MOI = 1.2, i.e., cor-
responding to 0.1 ug/ml L. infantum gDNA) still potently 
  induced IFN-α/β (Fig. S1 B).
No IFN-α/β was measurable when TLR9−/− pDCs 
were stimulated with L. infantum gDNA or when WT pDCs 
were exposed to L. infantum lysates treated with DNase, 
L. infantum gDNA treated with DNase, L. infantum mito-
chondrial kinetoplast DNA (kDNA), mouse splenic gDNA, 
human blood gDNA, or to apoptotic (UV-irradiated or 
  peroxynitrite-treated) annexin V+ pDCs. The DNase used did 
not exert nonspecifi  c inhibitory eff  ects because the IFN-α/β–
inducing activity of ssRNA remained unaltered (Fig. 3 A, top 
and bottom, and not depicted). Thus, the TLR9-dependent 
IFN-α/β release is parasite gDNA specifi  c and is not due to 
the recognition of self-DNA.
As TLR9 is expressed in endosomal and lysosomal com-
partments and requires an acidic pH to interact with ODN or 
DNA ligands (48), we tested whether chloroquine, which pre-
vents endosomal acidifi  cation, can inhibit Leishmania-induced 
IFN-α/β release. Both the CpG ODN– and the Leishmania-
induced IFN-α/β production were blocked by chloroquine 
without detectable toxicity as assessed by trypanblue exclu-
sion (not depicted). This fi  nding suggested that Leishmania 
Figure 3.  Parasite requirements for TLR9-dependent Leishmania-
specifi  c IFN-𝗂/𝗃 production of pDCs. (A) IFN-α/β activity (VSV bio-
assay) in the culture supernatants of FACS-sorted C57BL/6 or TLR9−/− 
BM-pDCs stimulated for 48 h with viable L. infantum promastigotes 
(MOI = 3) in the absence or presence of 500 U/ml DNase I, L. infantum 
freeze-thaw lysate (MOI = 3, without or with DNase I treatment), 5 μg/ml 
of synthetic GU-rich ssRNA (without or with DNase I treatment), or 
500 U/ml DNase I alone (A, top; mean ± SEM of three experiments) or with 
L. infantum promastigotes (MOI = 3), L. infantum gDNA, or L. infantum 
kDNA (A, bottom; mean ± SEM of two experiments). Signifi  cant differ-
ences (WT vs. KO, gDNA vs. kDNA) are indicated as follows: *, P < 0.05; 
**, P < 0.01; ***, P < 0.005. (B) C57BL/6 BM-MΦ, sorted BM-mDCs, or 
sorted C57BL/6 BM-pDCs (from Flt3L-BM culture) were stimulated with 
L. infantum promastigotes (MOI = 3) for 16 h. After staining of the cell 
surface (anti-CD11c or anti–Siglec-H) and of the parasites, the number 
of infected cells, noninfected cells, or cells with attached parasites was 
determined microscopically by evaluation of at least 100 cells in different 
visual fi  elds. Mean ± SEM of six (pDCs), four (mDCs), or three (BM-MΦ) 
separate experiments. Examples of the double immunofl  uorescence 
  staining of pDCs or mDCs and L. infantum are shown in the lower panels. 
▼, not detectable. Bar, 10 μM.JEM VOL. 204, April 16, 2007  897
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promastigotes might enter an acidic endosomal compartment 
of pDCs. However, multicolor fl   uorescent microscopy of 
sorted C57BL/6 pDCs (CD11b−CD11c+CD62L+), mDCs 
(CD11b+CD11c+), and BM-derived macrophages (BM-MΦ) 
revealed that mDCs and BM-MΦ, but not pDCs, internalize 
L. infantum promastigotes. Importantly, parasites were attached 
to the surface of  10% of the pDCs (Fig. 3 B). When parasites 
and pDCs were separated by a transwell membrane, no induc-
tion of IFN-α/β was observed (64,049 and 64,618 U/ml vs. 
<1 U/ml in two experiments).
Collectively, these data indicate that the activation of 
pDCs by Leishmania promastigotes for the production of IFN-
α/β requires cell–cell contact, but not uptake of the parasites. 
Leishmania gDNA is a potent inducer of IFN-α/β and is likely 
to contribute to the stimulatory activity of intact parasites.
The NK cell response to L. infantum in vivo 
is weakly impaired in IFNAR−/− mice and unaffected 
in pDC-depleted mice
The strong activation of pDCs for the release of IFN-α/β by 
Leishmania promastigotes in vitro led us to investigate whether 
this process also occurs in vivo and is relevant for the initia-
tion of the NK cell response to the parasite. We used a model 
of visceral (i.e., hepatic, splenic, and BM) leishmaniasis (49) 
because BM-derived and splenic pDCs were highly respon-
sive to our viscerotropic strain of L. infantum and therefore 
might also sense the parasite in vivo.
In C57BL/6 WT mice, i.v. infection of L. infantum led to 
a striking induction of NK cell cytotoxic activity that was 
maintained in IFNAR−/− mice (Fig. 4 A). In the spleen, 
L. infantum caused an increased IFN-γ mRNA expression 
within 8 h of infection (Fig. S2, available at http://www
.jem.org/cgi/content/full/jem.20061293/DC1) and the pro-
duction of IFN-γ protein by NK cells. The percentage of 
IFN-γ+ cells within the NK1.1+CD3− splenic NK cell pop-
ulation was similar in WT and IFNAR−/− mice at the 12-h 
time point but was signifi  cantly reduced at 24 h of infection 
in the IFNAR−/− group (Fig. 4 B). These results suggest that 
the L. infantum–induced and IFNAR-dependent secretion of 
IFN-α/β by pDCs that we observed in vitro is only partially 
involved in the activation of NK cells and/or does not occur 
to the same extent in vivo. In line with the latter possibility, 
we consistently found only a very weak induction (approxi-
mately factor 3–4) of IFN-α/β mRNAs in L. infantum–
  infected C57BL/6 WT mice (Fig. S2; see also WT mice in 
Fig. S4 A and Fig. 8 C), which was comparable in IFNAR−/− 
mice (Fig. S2). In addition, IFN-α or IFN-β protein was not 
detectable by ELISA in the serum or plasma of various strains 
of WT mice (C57BL/6, 129Sv, and BALB/c) within 4–24 h 
after L. infantum infection (not depicted).
To directly address the role of pDCs, we injected the 
pDC-specifi   c anti–PDCA-1 mAb twice before infection, 
which led to an  80–90% reduction of the Siglec-
H+CD11c+CD11b− splenic pDCs at all time points of infec-
tion tested (not depicted). This depletion protocol completely 
blocked the pDC-dependent IFN-α production in mice (50) 
elicited by i.v. injection of CpG ODN (Fig. S3, available at 
http://www.jem.org/cgi/content/full/jem.20061293/DC1). 
In contrast, control IgG–treated or pDC-depleted C57BL/6 
or 129Sv mice infected with L. infantum showed comparable 
levels of NK cell cytotoxicity, IFN-γ production, and splenic 
IFN-α4 and IFN-β mRNA expression (Fig. 4, C and D, and 
not depicted). Thus, pDCs are unlikely to control the early 
NK cell response to L. infantum.
The innate NK cell response to L. infantum requires IL-12 
and CD11chigh DCs
Because IFN-α/β had only a limited impact on the NK cell 
activation during the early phase of L. infantum infection, we 
tested whether IL-12 controls the onset of the NK cell re-
sponse in visceral leishmaniasis. i.v. infection with L. infantum 
led to strong NK cell cytotoxicity and IFN-γ expression in 
WT mice, but not in IL-12p35/p40−/− (devoid of IL-12 and 
IL-23) or IL-12p35−/− mice (devoid of IL-12; Fig. 5, A–D). 
Thus, IL-12 is essential for the activation of NK cells in 
L.   infantum–infected mice. Given that mDCs were more potent 
producers of IL-12 than pDCs (notably after cross-linking of 
CD40; Fig. 2 D) and that the depletion of pDCs did not 
prevent the L. infantum–induced NK cell response (Fig. 4, 
C and D), we postulated that the IL-12–dependent NK cell 
activation in vivo is driven by mDCs.
Figure 4.  Role of IFN-𝗂/𝗃 and pDCs for NK cell cytotoxicity and 
IFN-𝗄 expression in the spleens of mice infected i.v. with 107 
L. infantum promastigotes. (A and B) C57BL/6 WT versus IFNAR−/− mice. 
Mean ± SEM of four experiments with one to two mice per time point and 
mouse group. (C and D) Splenic pDCs of C57BL/6 mice were depleted by 
injection of 500 μg anti–mPDCA-1 mAb 24 and 4 h before infection with 
L. infantum. Control mice received rat IgG. Mean ± SEM of three experiments 
(C) or one of three experiments (D). (A and C) 24 h after injection of PBS or 
L. infantum, spleen cells were prepared and NK cell cytotoxic activity was 
measured. Infected WT mice were signifi  cantly different from PBS controls 
(*, P < 0.05; **, P < 0.01), but not from IFNAR−/− or anti–mPDCA-1–treated 
mice. (B and D) 12 and 24 h after infection, spleen cells were restimulated 
in medium ± YAC tumor cells (ratio 1:1) and stained for CD3−NK1.1+ NK 
cells and intracellular IFN-γ. **, P < 0.01 WT versus IFNAR−/−.898  PDCS, MDCS, TLR9, AND LEISHMANIA | Schleicher et al.
To investigate this directly, we used CD11c-diphtheria 
toxin (DT) receptor (DTR)/GFP mice that carry a transgene 
encoding a fusion protein of DTR and GFP under control of 
the promoter of the mouse CD11c gene (51). 2 d after injec-
tion of DT, CD11chighMHCII+CD11b+ splenic mDCs were 
ablated, whereas pDCs and all other CD11cint cells remained 
unaff  ected (Fig. 6 A). In agreement with a previous report 
(52), we observed that the DT treatment not only depleted 
CD11chighMHCII+ mDCs, but also MOMA-1+ metallo-
philic macrophages (MMs) and ERTR-9+ marginal zone 
macrophages (MZMs) in the spleen (Fig. 6 B). However, 5 d 
after DT treatment, CD11chighMHCII+ mDCs had repopu-
lated the spleen to a large, albeit varying extent in individu-
ally analyzed mice (Fig. 6 C), whereas ERTR-9+ MZMs 
remained completely depleted, and only very few MOMA-1+ 
MMs became visible in all 10 individually analyzed mice 
(Fig. 6 D). F4/80+ red pulp macrophages were not signifi  -
cantly aff  ected by the DT treatment in CD11c-DTR/GFP 
mice (51, 52; not depicted), and the percentage of CD11b+ 
cells even increased at days 2 and 5 after DT treatment (Fig. 
6 A and not depicted).
When WT and CD11c-DTR/GFP mice were treated 
with DT, infected with L. infantum 24 h later, and analyzed 
12 or 24 h after infection (i.e., at day 2 after DT), up-regula-
tion of IFN-γ mRNA in the spleen, activation of NK cells, 
and IL-12p40 production of mDCs were seen in infected 
WT mice, but not in the transgenic mice (Fig. 7, A and B, 
and Fig. S4, A and B, which is available at http://www.jem
.org/cgi/content/full/jem.20061293/DC1). Importantly, 
the number of splenic NK cells (CD3−NK1.1+) and their 
expression of IFN-γ after in vitro activation with the DC-
independent stimuli PMA/ionomycin was comparable in 
DT-treated naive or infected WT and CD11c-DTR/GFP 
mice, except for a more prominent IFN-γ production in the 
case of infected WT mice, which refl  ects the prior DC-
  dependent priming of NK cells by L. infantum in vivo (Fig. 
S5, A and B). The L. infantum–induced up-regulation of 
IFN-α4, IFN-α5, and IFN-β mRNA at day 2 after DT was 
 1,000-fold higher in the spleen of CD11chigh mDC-
  depleted mice than in the respective control mice (Fig. S4 A), 
which, however, did not rescue the NK cell response in those 
mice. At day 5 after DT, in contrast, NK cell cytotoxicity and 
IFN-γ production after L. infantum infection were clearly 
  restored in CD11c-DTR/GFP mice (Fig. 7, C and D). 
  Considering the varying degree of restoration of NK cell 
  activation, the spleens of 10 CD11c-DTR/GFP mice were 
split and analyzed in parallel by FACS, immunohistology, 
Figure 5.  NK cell cytotoxicity and IFN-𝗄 expression in the spleens 
of C57BL/6 WT versus IL-12p35/p40−/− and BALB/c WT versus 
IL-12p35−/− mice infected i.v. with 107 L. infantum promastigotes. 
(A and C) 24 h after injection of PBS or L. infantum, spleen cells were 
prepared and NK cell cytoxic activity was measured. Mean ± SEM of two 
experiments (two mice/group). (B and D) 12 and 24 h after infection, 
spleen cells of WT and KO mice were restimulated in medium ± YAC 
  tumor cells (ratio 1:1) and stained for CD3−NK1.1+ NK cells and intra-
cellular IFN-γ. One (B) or mean ± SEM (D) of two experiments with one 
to two mice per time point and mouse group. (A, C, and D) The values 
obtained for infected WT mice are signifi  cantly different from WT PBS con-
trols and from infected KO mice. *, P < 0.05; **, P < 0.01; ***, P < 0.005.
Figure 6.  Phenotypic analysis of the spleens of C57BL/6 WT and 
CD11c-DTR/GFP transgenic mice 2 or 5 d after i.p. injection of DT 
and 12–24 h after i.v. infection with 107 L. infantum promastigotes. 
(A and C) Flow cytometric analysis of DC populations in the spleen. The 
percentage of the respective cell population is given in the plot panels. 
(B and D) Immunohistological staining of MZMs (ERTR-9+) and MMs 
(MOMA-1+) in the spleen. Nuclei were counterstained with Meyer’s hemalaun. 
Bar, 100 μm. (A and B) One of fi  ve experiments, with two to three mice 
per mouse group. (C and D) One of two experiments, with 2–10 mice 
per mouse group. In C, two individual mice of the group of a total of 10 
infected CD11c-DTR/GFP mice with different DC reconstitution are shown.JEM VOL. 204, April 16, 2007  899
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and NK cell cytotoxicity assays, which revealed that the mag-
nitude of NK cell cytotoxicity solely correlated with the per-
centage of reconstitution of CD11chighMHCII+ mDCs (r2 = 
0.77; Fig. S6). MZMs and MMs were uniformly absent and 
the distribution and expression level of CD11b+ or F4/80+ 
in the red pulp were comparable in all mice tested (not de-
picted). A similar correlation was seen between NK cell IFN-γ 
production and the reconstitution of CD11chighMHCII+ 
mDCs (r2 = 0.66; not depicted). We conclude that activation 
of NK cells during the innate phase of L. infantum infection 
requires IL-12 and the presence of CD11chigh DCs, but not 
of MZMs or MMs.
TLR9 is required for the production of IL-12 and the 
activation of NK cells in L. infantum–infected mice
The critical role of mDCs and IL-12 for the activation of NK 
cells in L. infantum–infected mice and the TLR9-dependent 
production of IL-12 by mDCs in vitro led us to investigate 
whether TLR9 is essential for the expression of IL-12 and the 
initiation of the NK cell response in vivo. As observed 
before, i.v. infection of WT mice with L. infantum promasti-
gotes was followed by a rapid induction of NK cell cytotoxicity 
and IFN-γ protein expression in the spleen. In TLR9−/− 
mice, in contrast, no NK cell activation was measurable in 
response to L. infantum (Fig. 8, A and B). Both the number 
of NK cells as well as the activation of NK cells by the TLR3 
ligand poly(I:C) remained unaltered, indicating that the dele-
tion of TLR9 does not lead to the depletion or to a universal 
functional suppression of NK cells (Fig. 8 B and not depicted).
The diff  erence in the IFN-γ expression between WT and 
TLR9−/− mice during the innate phase of L. infantum infec-
tion was also seen by quantitative RT-PCR analysis of RNA 
samples prepared from total splenic tissue. In accordance with 
the TLR9-dependent production of type I IFNs and IL-12p40 
by pDCs and/or mDCs in vitro, the L. infantum–  induced ex-
pression of IFN-α4, IFN-β, and IL-12p40 mRNA was re-
duced in TLR9−/− compared with WT mice. However, due 
to the cell type–restricted expression and up-regulation 
of type I IFNs and IL-12, the factors by which the mRNA 
levels of these cytokines were increased in the spleen of WT 
mice after infection were not high enough to allow for sig-
nifi  cant diff  erences between WT and TLR9−/− mice for all 
genes, at all time points of infection, and in each individual 
experiment (Fig. 8 C and not depicted). To defi  nitively 
answer the question of TLR9-dependent expression of IL-12 
in vivo, we resorted to single cell analyses using intracellular 
cytokine staining. In the spleen of L. infantum–infected mice, 
IL-12p40 protein was exclusively found in CD11chigh mDCs 
( 1% of all living spleen cells; see Fig. 6 A), but not in 
F4/80+ macrophages (not depicted). As shown in Fig. 
8 D, the L. infantum–induced production of IL-12p40 by 
CD11chigh mDCs in the spleen and its accumulation in the 
plasma of WT mice were absent in TLR9−/− mice. IL-12p70 
was not detectable in the plasma samples (not depicted).
Collectively, these data show that TLR9 is strictly re-
quired for the activation of NK cells in visceral leishmaniasis 
because it is essential for the production of IL-12 by CD-
11chigh mDCs.
DISCUSSION
In the past, only few studies had analyzed the role of NK cells 
in visceral leishmaniasis. In untreated Indian patients with vis-
ceral leishmaniasis, the cytolytic activity of peripheral blood 
NK cells was reduced (53). In experimental visceral leishman-
iasis, NK cell–defi  cient beige mice (bg/bg) failed to eliminate 
L. donovani (23). After transfer of syngeneic cloned NK cells 
into bg/bg mice, the splenic parasite burdens were indistin-
guishable from those of normal WT mice (24). Finally, a 7-d 
treatment of BALB/c mice with IL-12 led to a 70% reduction 
of the liver parasite load compared with untreated control 
mice, whereas in IL-12–treated but NK cell–depleted mice, 
the decrease of the parasite numbers was only 30% (25). Col-
lectively, all these earlier observations argued for a protective 
function of NK cells during primary visceral leishmaniasis. 
Figure 7.  NK cell cytotoxicity and IFN-𝗄 expression in C57BL/6 
WT and CD11c-DTR/GFP transgenic mice 2 or 5 d after i.p. injection 
of DT and 12–24 h after i.v. infection with 107 L. infantum pro-
mastigotes or injection of PBS. (A) NK cell cytotoxicity of splenocytes 
at day 2 after DT. Mean ± SEM of fi  ve experiments, with two to three 
mice per time point and mouse group. ***, P < 0.005, WT L. infantum 
compared with WT PBS and CD11c-DTR L. infantum. (B) Intracellular IFN-γ 
staining of NK cells (CD3−NK1.1+) in splenocytes at day 2 after DT that 
were restimulated in medium ± YAC tumor cells (ratio 1:1). Staining of 
individual mice of one experiment is shown (day 5 analysis of the same 
experiment is illustrated in D). Similar results were obtained in fi  ve inde-
pendent experiments. (C) NK cell cytotoxicity of splenocytes at day 5 after 
DT. Results of one of two similar experiments are shown, with 2–10 mice 
per mouse group. *, P < 0.05; **, P < 0.01, WT and CD11c-DTR L. infantum–
infected mice compared with the respective PBS control. (D) Intracellular 
IFN-γ staining of NK cells in splenocytes at day 5 after DT (restimulated 
as in B). One of two independent experiments.900  PDCS, MDCS, TLR9, AND LEISHMANIA | Schleicher et al.
However, neither the process of innate NK cell activation 
nor the underlying mechanisms have been investigated in 
the past.
To the best of our knowledge, this study is the fi  rst to dem-
onstrate that the activation of NK cell functions in vivo 
  requires the presence of mDCs (but not pDCs). Previous 
analyses in tumor or viral models were based on the applica-
tion of anti-CD8 antibodies (which deplete CD8α+ lym-
phoid cells without being selective for these cells) and/or did 
not directly investigate the eff  ector functions of NK cells 
  (cytotoxicity and IFN-γ production; references 11, 12, and 54). 
Another novelty of our report is the strict requirement of 
TLR9 for the induction of an NK cell response to a nonviral 
pathogen. This is particularly surprising, because unlike DNA 
viruses that were shown to drive NK cell activation in a 
TLR9-dependent manner (55, 56), Leishmania parasites are 
complex, eukaryotic pathogens that express a wide variety of 
possible ligands for pattern recognition receptors. Our re-
sults show that the early NK cell response to a visceral infec-
tion with L. infantum is completely dependent on TLR9, 
CD11chigh mDCs, and IL-12, weakly impaired in the ab-
sence of IFN-α/β, and unaff  ected after depletion of pDCs. 
Therefore, this study off  ers a coherent picture of the receptor, 
cellular, and cytokine requirements of NK cell activation 
in vivo. Finally, the essential role of TLR9 for innate NK cell 
activation observed here might serve as a plausible explana-
tion for the previously reported TLR9 dependency of adap-
tive Th1 immune responses in other microbial infection 
models (45, 46, 57).
pDCs, IFN-𝗂/𝗃, and TLR-9–dependent NK cell activation
Exposure of pDCs to promastigotes of diff  erent Leishmania 
species led to a rapid induction of IFN-β and a broad spec-
trum of IFN-α isoforms. The IFN-α/β release was not de-
pendent on the parasite stage, replication, viability, integrity, 
or uptake but required a direct contact between the pDCs 
and the promastigotes, and an acidifi  cation of endosomal/ 
lysosomal compartments that are thought to carry the TLR9 
receptor (19, 48). Genomic, but not the evolutionary ancient 
mitochondrial (kinetoplast) DNA of Leishmania parasites, was 
suffi   cient to mimic the TLR9-dependent induction of IFN-
α/β by intact promastigotes. At fi   rst glance, the TLR9-
  dependent and chloroquin-inhibitable stimulation of pDCs 
by intact promastigotes is diffi   cult to reconcile with the 
Figure 8.  NK cell cytotoxicity, NK cell IFN-𝗄 production, and 
cytokine expression in the spleens of WT and TLR9−/− mice in-
fected i.v. with 107 L. infantum promastigotes. (A) NK cell cytoxicity 
of splenocytes at 24 h after infection. Mean ± SEM of four independent 
experiments. *, P < 0.05, WT L. infantum compared with WT PBS or 
TLR9−/− L. infantum. (B) 12 h after injection of L. infantum, PBS or poly
(I:C) (50 μg, i.p.) spleen cells of WT and TLR9−/− mice were restimulated 
in medium ± YAC tumor cells (ratio 1:1) and stained for NK cells 
(CD3−NK1.1+) and intracellular IFN-γ. One of three similar experiments. 
(C) IFN-α4, IFN-β, IFN-γ, IL-12p35, and IL12p40 mRNA expression in the 
spleens 3, 6, 9, 12, and 24 h after infection. PBS control mice were set as 
1 (mean ± SEM of three experiments; in each experiment two mice per 
time point and mouse group were analyzed by real-time RT-PCR with 
triplicate determinations for each gene). Inset: Relative cytokine mRNA 
expression levels (compared with the mHPRT-1 housekeeping gene) in 
the spleen 6 h after infection (mean ± SEM of three experiments). 
(D) Top panels: 12 h after injection of PBS or L. infantum, spleen cells of 
WT and TLR9−/− mice were restimulated in medium and stained for CD11c+ 
DCs and intracellular IL-12p40 protein (one of three similar experiments; 
the percentage of IL-12p40+ cells is indicated in the panels; mean ± 
SEM of three independent experiments is shown in the graph below). 
***, P < 0.001, WT L. infantum compared with WT PBS and TLR9−/− 
L. infantum. Bottom: IL-12p40 plasma levels of 12-h–infected or PBS 
control mice as measured by ELISA (mean ± SEM of three independent 
experiments). ***, P < 0.001, WT L. infantum compared with WT PBS and 
TLR9−/− L. infantum.JEM VOL. 204, April 16, 2007  901
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  absence of detectable parasite uptake in pDC/Leishmania co-
cultures. However, as extrusion of gDNA by viable eukaroytic 
cells has been observed (58), and DNase treatment signifi  -
cantly ( 75%) reduced the production of IFN-α/β by pDCs 
exposed to Leishmania, our results are compatible with the 
idea that gDNA released by promastigotes during their at-
tachment to pDCs accounts for the strong induction of IFN-
α/β. We wish to point out that our fi  ndings do not exclude 
the possibility that another, so far unknown, heat-resistant 
component of Leishmania functions as TLR9 ligand and con-
tributes to the activation of pDCs to produce IFN-α/β by 
intact parasites. In this respect, it is noteworthy that at least 
one non-DNA ligand of TLR9, i.e., hemozoin (a degradation 
product of host cell–derived heme in Plasmodium-infected 
erythrocytes), has been described that triggered human, but not 
mouse, pDCs for the release of IFN-α/β (18, 59).
In light of the strong production of IFN-α/β by pDCs 
exposed to L. infantum in vitro, the observation that a 90% 
reduction of the number of pDCs in the spleen did not aff  ect 
the Leishmania-induced NK cell response was unexpected. As 
there was only a limited up-regulation of type I IFN mRNAs 
in the infected spleen that was not altered by the depletion of 
pDCs, splenic pDCs might not be targeted and/or activated 
by L. infantum in vivo during the early phase of infection. In 
this respect, visceral leishmaniasis diff  ers from viral infection 
models in which pDC depletion resulted in a decrease of the 
expression of IFN-α (55, 60). However, even in viral infec-
tions pDCs are not necessarily required for NK cell cytotoxic 
activity (55). The fact that pDCs were dispensable for the 
elicitation of an innate NK cell response in L. infantum–
  infected mice does not exclude that the interaction between 
pDCs and Leishmania might be relevant during later stages of 
visceral leishmaniasis.
Our analysis of IFNAR−/− mice revealed that IFN-α/β 
(possibly released by cells other than pDCs) contributes to the 
induction of NK cell IFN-γ expression, but not of NK cell 
cytotoxicity in L. infantum–infected mice. This contrasts with 
(a) the role of IFN-α/β in mouse cytomegalovirus–infected 
mice, in which IFN-α/β was required for the induction of 
NK cell cytotoxicity, but not IFN-γ expression (61); and (b) 
with the function of IFN-α/β in experimental cutaneous 
leishmaniasis, where anti–IFN-α/β drastically reduced both 
the NK cell cytotoxicity and the early IFN-γ peak in the 
draining lymph nodes of L. major–infected mice (28). pDCs 
have been detected in the lymph nodes of L. major–infected 
mice (62), but whether they are necessary for the innate NK 
cell response and account for the previously reported early 
IFN-α/β production in cutaneous leishmaniasis (28) has not 
yet been investigated.
CD11chigh mDCs, IL-12, and TLR9-dependent 
NK cell activation
CD11c-DTR/GFP transgenic mice (51) are currently the 
only mouse model to eliminate CD11chigh DCs. To the best 
of our knowledge, this is the fi  rst study in which these mice 
have been used to demonstrate that CD11chigh DCs are 
  necessary for the priming of NK cell functions (IFN-γ pro-
duction and cytotoxicity) in vivo. Recently, it was reported 
that DT treatment of CD11c-DTR/GFP mice, in addition 
to CD11chigh DCs, also depletes MZMs and MMs in the 
spleen (52), which we could confi  rm in both naive and 
L. infantum–infected mice (Fig. 6 and not depicted). Although 
viscerotropic Leishmania parasites were previously shown to 
selectively activate DCs, but not MZMs, of the spleen (41), 
we carefully addressed the potential role of MZMs and MMs 
for the activation of NK cells. The time course and functional 
analyses shown in Fig. 6, Fig. 7, and Fig. S6 demonstrated 
that in L. infantum–infected, DT-treated CD11c-DTR/GFP 
mice, NK cell activation was rapidly restored once CD11chigh 
DCs repopulated the spleen, although at these time points 
both MZMs and MMs were still absent. Thus, NK cell acti-
vation requires CD11chigh DCs, whereas MZMs and MMs 
are clearly dispensable. It is also unlikely that the absence of 
NK cell activation in L. infantum–infected, DT-treated 
CD11c-DTR/GFP mice results from a suppressive or toxic 
eff  ect of DT or dead DCs on NK cells. First, DT treatment 
did not reduce the number of NK cells. Second, DT did not 
impair the response of NK cells to PMA/ionomycin 
(Fig. S5). Third, the function of NK cells was fully restored 
after the repopulation of CD11chigh DCs, which further 
  excludes a cytotoxic or long-lasting suppressive eff  ect of DT 
on splenic NK cells.
The TLR9-dependent induction of IL-12p40 by L. infantum 
in mDCs in vitro (Fig. 2 D) and in vivo (Fig. 8 D), the equally 
absent innate NK cell response to L. infantum in TLR9−/−, 
IL-12−/−, and CD11chigh-depleted mice (Figs. 5, 7, and 8), 
and the lack of infection-induced IL-12p40 expres  sion in 
CD11chigh-depleted mice (Fig. S4 B) strongly argues for the 
following model of NK cell activation in which TLR9, 
mDCs, IL-12, and NK cells are coherently linked: L. infantum 
activates CD11chigh DCs via TLR9 for the generation of 
IL-12 that subsequently triggers NK cell cytotoxicity and 
IFN-γ production. The dominant role of mDCs and IL-12 is 
further underlined by the observation that the depletion of 
CD11chigh mDCs before L. infantum infection did not diminish 
the number of splenic pDCs (Fig. 6 A) and was accompanied 
by a roughly 1,000-fold increase of the IFN-α and IFN-β 
mRNA expression (Fig. S4 A), which, however, was insuffi   -
cient to prevent the loss of NK cell activity. Our results also 
off  er a mechanistic and functional explanation for the close 
and prolonged interactions between NK cells and mDCs that 
were recently seen in the lymph nodes of mice infected with 
L. major (experimental cutaneous leishmaniasis) using intra-
vital microscopy (31).
Human NK cells were previously shown to express 
TLRs, including TLR2, TLR3, and TLR9 (63–65). This led 
us to consider whether L. infantum might directly activate 
mouse NK cells in a TLR9-dependent manner. Previous 
and present observations strongly argue against this possi-
bility. First, FACS-sorted, IL-2–expanded mouse splenic 
NK1.1+CD3− NK cells did not express TLR9 mRNA as 
assessed by RT-PCR (unpublished data). Second, FACS-sorted, 902  PDCS, MDCS, TLR9, AND LEISHMANIA | Schleicher et al.
IL-2–expanded or MACS-sorted (DX5+) naive splenic NK 
cells were neither activated by CpG ODN (55) nor by Leish-
mania promastigotes (unpublished data) for the expression 
of IFN-γ or cytolytic activity. Third, in the absence of 
  CD11chigh DCs or IL-12, no NK cell activity was detectable 
in L. infantum–infected mice.
In summary, this study revealed an unexpected, dominant 
role of TLR9 for the initiation of the NK cell response to a 
complex eukaryotic pathogen. Although initial in vitro ex-
periments suggested that both pDCs and mDCs are valid 
candidates to deliver activating signals to NK cells, our in 
vivo analyses demonstrated that TLR9, CD11chigh mDCs, 
and IL-12, but not pDCs and type I IFNs, were essential for 
NK cell cytotoxicity and IFN-γ production in visceral leish-
maniasis. The observed TLR9- and IL-12–dependent NK 
cell activation by mDCs suggests a certain hierarchy within 
the receptors, cell types, and cytokines previously shown to 
exert activating eff  ects on NK cells, which might also hold 
true for infections with other intracellular pathogens.
MATERIALS AND METHODS
Mice, parasites, and infection
Female C57BL/6, BALB/c, and 129Sv (PasIco) mice were from Charles River 
Laboratories, and CD11c-DTR/GFP transgenic mice (15th generation back-
cross to C57BL/6; reference 51) were from The Jackson Laboratory. Breeding 
pairs of IL-12p35−/− mice (fi  fth generation backcross to BALB/c; reference 34) 
and IL-12p35/p40−/− mice (10th generation backcross to C57BL/6; ref-
erence 34) were provided by G. Alber (University of Leipzig, Leipzig, Germany) 
and H. Mossmann (Max Planck Institute for Immunobiology, Freiburg, 
Germany), respectively. IFNAR−/− (66), IFN-β−/− (67), MyD88−/− (68), 
and TLR9−/− mice (69) were backcrossed to C57BL/6 mice for 10, 13, 8, or 10 
generations, respectively. All mice were housed under specifi  c pathogen-free 
conditions and used at the age of 6–12 wk.
Promastigotes of L. major (MHOM/IL/81/FEBNI; reference 70), 
L. infantum (MHOM/00/98/LUB1; reference 71), and L. braziliensis (MHOM/
BR/94/H-3227; reference 72) were grown from amastigotes isolated from 
skin lesions of BALB/c (L. major and L. infantum) or iNOS−/− (L. braziliensis) 
mice and propagated in vitro (70).
For infection, mice were injected i.v. in the retro-orbital vein or in the 
tail vein with 300 μl PBS or 107 stationary phase L. infantum promastigotes 
in 300 μl PBS. The animal experiments were approved by the animal wel-
fare committee of the Regierungspräsidium Freiburg.
In vivo treatment
To deplete pDCs, mice were i.p. injected with 500 μg rat anti–mPDCA-1 
mAb or control rat IgG (The Jackson Laboratory) at 24 and 4 h before i.v. 
injection of L. infantum, 5 μg of a phosphorothioate-modifi  ed CpG ODN 
(50), or PBS. The CpG ODN was mixed with 30 μl of the cationic lipo-
some preparation DOTAP (Roche Diagnostics) in a volume of 300 μL PBS 
(50). 4, 6, 8, 12, and 24 h after infection, spleen cells were analyzed for the 
presence of CD11b−CD11cintSiglec-H+ cells to control depletion. To de-
plete mDCs, CD11c-DTR/GFP mice received an i.p. injection of DT 
(4 ng/g body weight; Sigma-Aldrich) 1 or 4 d before L. infantum infection. 
The reduction of CD11chighMHCII+ mDCs was controlled by FACS analy-
sis. The depletion of macrophages in DT-treated CD11c-DTR/GFP mice 
was monitored by immunohistology of the spleen. For activation of NK cells 
in vivo, mice received i.p. 50 μg poly(I:C) (Sigma-Aldrich).
FACS analysis
For surface phenotyping and cell sorting, the following unconjugated, 
  fl   uorochrome (FITC-, PE-, or APC-) -labeled or biotinylated mAbs 
were used (all from BD Biosciences unless otherwise stated): anti-CD11b 
(M1/70), anti-Ly6C (ER-MP20; BMA Biomedicals), anti-Ly6G (Gr-1), 
anti-CD62L (MEL-14), anti-CD11c (HL3), anti-CD45R/B220 (RA3-
6B2), anti–I-A/I-E (M5/114.15.2), anti-CD40 (3/23), anti-CD80 (16-
10A1), anti-CD86 (GL1), anti-NK1.1 (PK136), anti-CD49b (DX5), 
anti-CD3 (145-2C11), anti–mPDCA-1(Miltenyi Biotec), and anti–Siglec-H 
(440c; Hycult Biotechnology). Biotinylated antibodies were detected by 
streptavidin-APC or streptavidin-PE (BD Biosciences). The specifi  city of 
the stainings was verifi  ed by the use of isotype control mAbs. Propidium 
  iodide was included at 1 μg/ml in the fi  nal wash to detect dead cells. All 
  analyses were performed on a FACSCalibur (BD Biosciences) applying the 
CELLQuest Pro software. The FL3 channel was used to exclude propidium 
iodide+ dead cells.
Generation and purifi  cation of pDCs and mDCs
Splenic pDCs and mDCs. After collagenase D (Roche Diagnostics) treat-
ment, splenic DCs were enriched from total spleen cells by positive selection 
of CD11c+ cells using anti-CD11c MicroBeads and AutoMACS (Miltenyi 
Biotec). pDCs were obtained by MoFlo sorting (Cytomation Inc.) of 
CD11b−CD11cintGr-1+ cells, and mDCs were obtained by sorting of 
CD11b+CD11chigh cells (purity ≥95%). Purifi   ed mDCs also expressed 
MHC class II.
BM-pDCs. BM-pDCs were generated from total BM cells in the presence 
of Flt3L (73). After incubation in red blood cell lysis buff  er (Sigma-Aldrich), 
BM cells were cultured in complete RPMI with 100 ng/ml rmFlt3L (R&D 
Systems) for 7–8 d at 2 × 106 cells/ml (25 cm2 cell culture fl  asks, 5 ml). 
At day 4, 2.5 ml of medium per flask was replaced by 2.5 ml of fresh 
  medium with 50 ng/ml Flt3L. After 7–8 d, 75–95% of the cells were 
CD11c+. pDCs (CD11b−) represented 57–77% and mDCs (CD11b+) rep-
resented 23–43% of the CD11c+ population (unpublished data). At day 7 or 8, 
CD11b−CD11c+CD62L+ BM-pDCs were purifi  ed by MoFlo sorting 
(purity >95%). The purifi  ed pDCs were readily stained with anti-B220 and 
the pDC-specifi  c mAbs anti–Siglec-H (74) and anti–mPDCA-1 (15 and 
unpublished data).
BM-mDCs. BM-mDCs were either sorted as CD11c+CD11b+ cells from 
Flt3L-expanded BM-cultures (see above) or generated from BM cells incubated 
with rmGM-CSF (75). GM-CSF–expanded BM cultures (day 8) contained 
 80% CD11b+CD11chigh mDCs, which were further purifi  ed as immature 
CD11b+CD11c+CD86low mDCs by MoFlo sorting (purity ≥96%).
Stimulation of pDCs and mDCs
pDCs and mDCs were cultured in 96-well (105 cells/well, 250 μL), 24-well 
(106 cells/well, 1 ml), or 24-transwell tissue culture plates (106 cells/well; 
0.4-μm pore size, 700 μL; Corning Costar) at 37°C and 5% CO2/95% 
  humidifi  ed air using RPMI 1640 (Invitrogen) that was supplemented with 
50 μM 2-ME, 1% nonessential amino acids, 1 mM sodium pyruvate, 100 μg/ml 
kanamycin sulfate, and 10% FCS (PAA Laboratories) for pDC cultures or 
supplemented as described previously (29) plus 10% FCS (PAA) for mDC 
and all other cell cultures. Cells were activated for 12–72 h with 1 μM CpG 
ODN 2216 (Thermo Electron), 200 ng/ml LPS (Escherichia coli O111:B4; 
Sigma-Aldrich), 50 ng/ml poly(I:C) (Sigma-Aldrich), 20 ng/ml rmIFN-γ 
(provided by G. Adolf, Boehringer Ingelheim, Vienna, Austria), 5 μg/ml 
anti-mCD40 (clone 3/23; BD Biosciences), UV-inactivated HSV-1 (pro-
vided by T. Stamminger, University of Erlangen, Erlangen, Germany), 
Leishmania spp. promastigotes (logarithmic stage or stationary growth phase; 
parasite/pDC ratio [MOI] = 3:1, unless indicated diff  erently), 160 mJ/cm2 
of UV-irradiated L. major or L. infantum promastigotes (MOI = 3:1), Leish-
mania spp. antigen (freeze-thaw lysates of promastigotes; MOI = 3:1), 0.1–5 
μg/ml gDNA or kDNA of L. infantum promastigotes or with GU-rich 
  ssRNA double-right complexed with LyoVec (5μg/ml; ssRNA-DR/ 
LyoVec; InvivoGen). In some experiments, ssRNA, Leishmania DNA, or 
Leishmania lysates were digested with 500 U/ml of bovine pancreas DNase I 
(Sigma-Aldrich) before their addition to the pDC cultures according to the 
manufacturer’s protocol. gDNA of Leishmania spp. was prepared by proteinase JEM VOL. 204, April 16, 2007  903
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K digestion of promastigotes, followed by phenol/chloroform extraction 
and ethanol precipitation or by using the Blood&Cell Culture DNA kit 
(QIAGEN). In both cases, RNA was removed with DNase-free RNaseA 
(Invitrogen). kDNA was prepared as described previously (76) and con-
trolled by gel electrophoresis.
Cytokine and nitrite measurements
IFN-α/β levels were determined with a L929/vesicular stomatitis virus 
  protection assay using triplicates and serial twofold dilutions of the culture 
supernatants (28). Purifi  ed mouse IFN-α/β and a neutralizing sheep anti–
IFN-α/β antiserum (provided by I. Gresser, Institute Curie, Paris, France) 
was used as a standard or to ascertain that all antiviral activity in the 
  supernatants was due to IFN-α/β. The content of IFN-α (including IFN-α1, 
IFN-α4, IFN-α5, IFN-α6, and IFN-α9) or IFN-β (both from PBL 
Biomedical Laboratories), TNF (sensitivity 40 pg/ml; R&D Systems), MIP-2 
(sensitivity 20 pg/ml; Nordic Biosite), IL-12p40, or IL-12p70 (sensitivity 
40 pg/ml; BD Biosciences) was measured by ELISA. NO2
− was determined 
by the Griess assay (77).
Intracellular cytokine staining
IFN-γ staining in NK cells. Spleen cells of infected or control mice were 
restimulated for 6 h in the presence of 10 μg/ml brefeldin A with medium 
alone or with YAC-1 tumor target cells (ratio 1:1) for repeated priming of 
the NK cells or with 50 ng/ml PMA (Sigma-Aldrich) and 750 ng/ml iono-
mycin (Sigma-  Aldrich). After staining of NK cell surface markers (CD3-
NK1.1+ or CD3-DX5+), the cells were fi  xed with CytopermCytofi  x (BD 
Biosciences) for 20 min and incubated with APC-conjugated rat anti–mouse 
IFN-γ (XMG1.2; BD Biosciences) as described previously (77).
IL-12p40 staining in CD11c+ cells. Applying the same method as 
described above, spleen cells were restimulated with medium alone or, as a 
positive control, with 1 μM CpG ODN 1668 (Thermo Electron). For sur-
face staining, anti-CD11c, anti-CD11b, and anti-F4/80 (Cl:A3-1; Serotec) 
mAbs were used. IL-12p40 was stained by an APC-conjugated rat anti–
mouse IL-12p40/p70 mAb (C15.6; BD Biosciences).
NK cell cytotoxicity
After determining the percentage of NK1.1+CD3− or DX5+CD3− NK 
cells within whole spleen cells, the NK cell cytotoxicity against YAC-1 
  tumor cells was determined (27, 28).
Immunofl  uorescence microscopy
Purifi  ed BM-pDCs and BM-mDCs or BM-MΦ (77) were incubated with 
Leishmania promastigotes for 16 h. Thereafter, nonadherent pDCs and mDCs 
were transferred to adhesion slides (Marienfeld Lab. Glassware), whereas 
macrophages were directly stained in LabTek Permanox Chambers (Nalge 
Nunc Int.). For double immunofl  uorescence staining, the cells were blocked 
with PBS/1% BSA and incubated with biotinylated anti-CD11c (HL3; 
mDCs), anti–Siglec-H (pDCs), or anti-CD11b (macrophages) antibodies 
(BD Biosciences), followed by Cy3-conjugated streptavidin (Invitrogen). 
Internalized Leishmania parasites were stained after fi  xation in 3% parafor-
maldehyde and permeabilization in 1% saponin using human anti–L. major 
antiserum (78) and fl  uorescein–labeled anti–human IgG (Fab′)2 fragments 
(Dianova). Vectashield (containing DAPI to stain the nuclei; Vector Labora-
tories) -mounted slides were analyzed with an ApoTome-equipped Axio-
plan2 microscope connected to an AxioCam-MR digital camera (Carl Zeiss 
MicroImaging, Inc.).
Immunohistology
Immunohistochemistry of splenic acetone-fi  xed cryosections (5–6 μm) were 
performed using unconjugated rat anti-F4/80 (CI:A3-1), rat anti–mouse 
macrophage (MOMA-1), and rat anti–SIGN-R1 (ERTR-9) mAbs (all from 
BMA Biomedicals), followed by biotin-conjugated (Fab′)2 fragments of 
mouse anti–rat IgG or goat anti–rat IgM (μ chain specifi  c; both from 
  Dianova), alkaline phosphatase–conjugated streptavidin (DakoCytomation), 
and by a red alkaline phosphatase substrate (Vector Laboratories). Sections 
were counterstained with Meyer’s hemalaun, mounted with Aquatex 
(Merck), and analyzed by light microscopy (Axioskop 2 plus; Carl Zeiss 
  MicroImaging, Inc.).
RNA preparation and PCR
Total RNA was prepared using the RNeasy extraction kit (QIAGEN). 
Contaminant gDNA was removed with DNase (DNAfree; Ambion). The 
presence of gDNA was excluded by performing a PCR reaction with 
1 μL of the RNA sample as template and primers for mouse β-actin (sense: 
5′-C  A  C  C  C  G  C  C  A  C  C  A  G  T  T  C  G  C  C  A  -3′; antisense: 5′-C  A  G  G  T  C  C  C-
G  G  C  C  A  G  C  C  A  G  G  T  -3′). Total RNA (1–10 μg) was reverse transcribed 
using the High Capacity cDNA Archive kit (Applied Biosystems). Sub-
sequent real-time PCR was performed on an ABI Prism 7900 sequence 
detector (Applied Biosystems) using Taqman Universal Mastermix and 
Assays-on-Demand (Applied Biosystems), which include forward and reverse 
primers and the FAM-labeled probe for the target gene, respectively. The 
following assays were used: murine hypoxanthine guanine phosphoribosyl 
transferase 1 (mHPRT-1; Mm00446968_m1), mIFN-α2 (Mm00833961_s1), 
mIFN-α4 (Mm00833969_s1), mIFN-α5 (Mm00833976_s1), mIFN-α6 
(Mm01258374_s1), mIFN-α9 (Mm00833983_s1), mIFN-α11 (Mm01257312_
s1), mIFN-α12 (Mm00616656_s1), mIFN-α13 (Mm00781548_s1), mIFN-α14 
(Mm01703465_s1), mIFN-β (Mm00439546_s1), mIL-12p35 (Mm00434165_
m1), mIL-12p40 (Mm00434170_m1), mIFN-γ (Mm00801778_m1), and 
TLR9 (Mm00446193_m1). Each cDNA was amplifi  ed and measured in 
triplets with 50–100 ng cDNA per well in a reaction volume of 15 μL and 
the following cycle conditions: 2 min at 50°C, 10 min at 95°C, and then 15 s 
at 95°C and 60 s at 60°C for 40 cycles. mRNA levels were   calculated with 
the SDS 2.1 software (Applied Biosystems). The amount of mRNA of each 
gene was normalized to the housekeeping gene mHPRT-1. mRNA expres-
sion levels were calculated as the n-fold diff  erence relative to the housekeep-
ing gene by the formula: relative expression = 2−(C
T(target)
−C
T(mHPRT-1)
).
Statistics
Statistical analysis was performed using the unpaired Student’s t test.
Online supplemental material
Fig. S1 shows the up-regulation of costimulatory molecules and the dose-
dependent induction of IFN-α/β (determined by bioassay or ELISA) in 
pDCs upon exposure to Leishmania promastigotes. Fig. S2 presents quantita-
tive RT-PCR data on the expression of IFN-α/β and IFN-γ in C57BL/6 
WT and IFNAR−/− mice infected with 107 L. infantum. Fig. S3 illustrates 
the reduction of IFN-α production in mice challenged with CpG after prior 
depletion of pDCs. Fig. S4 shows the splenic expression of IFN-γ mRNA 
and type I IFN mRNAs as well as the expression of IL-12p40 protein in 
splenic DCs in DT-treated C57BL/6 WT and CD11c-DTR/GFP trans-
genic mice. Fig. S5 illustrates the percentage of NK cells and the PMA/ion-
omycin-induced expression of IFN-γ protein by NK cells in the spleens of 
C57BL/6 WT and CD11c-DTR/GFP transgenic mice after injection of 
DT and infection with L. infantum. Fig. S6 documents the linear correlation 
between NK cell cytotoxicity and DC reconstitution in the spleens of 
C57BL/6 WT and CD11c-DTR/GFP transgenic mice. Figs. S1–S6 are 
available at http://www.jem.org/cgi/content/full/jem.20061293/DC1.
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